These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21514447)

  • 1. Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.
    Arbini AA; Greco M; Yao JL; Bourne P; Marra E; Hsieh JT; di Sant'agnese PA; Moro L
    Am J Pathol; 2011 May; 178(5):2367-76. PubMed ID: 21514447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
    Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
    Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.
    Šimečková Š; Kahounová Z; Fedr R; Remšík J; Slabáková E; Suchánková T; Procházková J; Bouchal J; Kharaishvili G; Král M; Beneš P; Souček K
    Sci Rep; 2019 Apr; 9(1):5695. PubMed ID: 30952903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
    Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.
    Moro L; Arbini AA; Marra E; Greco M
    J Biol Chem; 2006 Aug; 281(31):22100-22107. PubMed ID: 16754685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.
    Jiang J; Pan Y; Regan KM; Wu C; Zhang X; Tindall DJ; Huang H
    Prostate; 2012 Feb; 72(2):225-32. PubMed ID: 21630295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
    Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
    Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
    Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
    Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
    Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
    Moro L; Arbini AA; Marra E; Greco M
    J Biol Chem; 2005 Jun; 280(23):22482-91. PubMed ID: 15805113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
    Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
    Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
    BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.
    Drobnjak M; Melamed J; Taneja S; Melzer K; Wieczorek R; Levinson B; Zeleniuch-Jacquotte A; Polsky D; Ferrara J; Perez-Soler R; Cordon-Cardo C; Pagano M; Osman I
    Clin Cancer Res; 2003 Jul; 9(7):2613-9. PubMed ID: 12855638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
    J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
    Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
    Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.
    Francis JC; McCarthy A; Thomsen MK; Ashworth A; Swain A
    PLoS Genet; 2010 Jun; 6(6):e1000995. PubMed ID: 20585617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.